Notice: This company has been marked as potentially delisted and may not be actively trading.

Agile Therapeutics (AGRX) Insider Trading & Ownership

Current Insider Ownership Percentage: 0.50%
Number Of Insiders Buying (Last 3 Years): 2
Amount Of Insider Buying (Last 3 Years): $4.90 M
Number Of Insiders Selling (Last 3 Years): 0

Get AGRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Agile Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AGRX Insider Buying and Selling by Quarter

Ad Insiders Exposed

Has Trump Finally Gone Too Far?

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Agile Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
8/26/2022	Alfred Altomari	CEO	Buy	50,000	$0.45	$22,500.00
10/13/2021	Perceptive Advisors Llc	Major Shareholder	Buy	5,734,560	$0.85	$4,874,376.00

(Data available from 1/1/2013 forward)

AGRX Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Agile Therapeutics includes Alfred Altomari, and Perceptive Advisors Llc. Learn more on insiders at AGRX.
: 0.50% of Agile Therapeutics stock is owned by insiders. Learn more on AGRX's insider holdings.